Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
about
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsExpanding the scope of site-specific recombinases for genetic and metabolic engineeringIn vivo bioluminescent imaging (BLI): noninvasive visualization and interrogation of biological processes in living animalsThe therapeutic potential of ΦC31 integrase as a gene therapy systemBioluminescence imaging allows monitoring hepatitis C virus core protein inhibitors in miceMaintenance of muscle stem-cell quiescence by microRNA-489Impact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinomaHarnessing a high cargo-capacity transposon for genetic applications in vertebratesDAXX interacts with phage PhiC31 integrase and inhibits recombination.Optimization of Streptomyces bacteriophage phi C31 integrase system to prevent post integrative gene silencing in pulmonary type II cells.Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activityMutational derivatives of PhiC31 integrase with increased efficiency and specificity.Hybrid lentivirus-phiC31-int-NLS vector allows site-specific recombination in murine and human cells but induces DNA damage.Gene and cell-mediated therapies for muscular dystrophy.A method for producing transgenic cells using a multi-integrase system on a human artificial chromosome vectorBiosafety assessment of site-directed transgene integration in human umbilical cord-lining cells.Gene therapy progress and prospects: Duchenne muscular dystrophy.Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophyMolecular-targeted therapy for Duchenne muscular dystrophy: progress and potential.Programmable Genome Editing Tools and their Regulation for Efficient Genome Engineering.Intragenic integration in DLC1 sustains factor VIII expression in primary human cells without insertional oncogenicity.Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells.Enhanced gene repair mediated by methyl-CpG-modified single-stranded oligonucleotidesInorganic nanovectors for nucleic acid delivery.Genomic integration of the full-length dystrophin coding sequence in Duchenne muscular dystrophy induced pluripotent stem cells.Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system.Long-term in vivo gene expression in mouse kidney using φC31 integrase and electroporation.α- L-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice.Genome Editing Techniques and Their Therapeutic Applications.Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.Bacteriophage phiC31 integrase mediated transgenesis in Xenopus laevis for protein expression at endogenous levels.Sequences in attB that affect the ability of phiC31 integrase to synapse and to activate DNA cleavage.Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase.Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase.DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.Ex vivo gene editing of the dystrophin gene in muscle stem cells mediated by peptide nucleic acid single stranded oligodeoxynucleotides induces stable expression of dystrophin in a mouse model for Duchenne muscular dystrophy.Blastocyst Formation Rate and Transgene Expression are Associated with Gene Insertion into Safe and Non-Safe Harbors in the Cattle Genome.Evaluating the efficiency of phiC31 integrase-mediated monoclonal antibody expression in CHO cells.
P2860
Q26777286-C699F5A1-5CF3-4A04-846E-45F085F45D3FQ26995224-E7D2B3AF-453D-44BE-B2C0-3C80654C9658Q27006069-192125F5-439B-4265-8414-CEBD5F14FECDQ28242655-44F978CB-D21C-4B31-ADFF-88C2EC734048Q28476181-4303CEF6-BB89-4E0E-8D32-C7208795C864Q28509431-D2728452-20EE-45BB-A59A-3997ACAB5A9CQ28750796-1A2646CB-1295-401E-93E1-72EC33A20062Q33263256-5BD3D354-2CC4-423A-986E-BE1B0FA4865AQ33263375-F4ADEB5B-F7CA-4BF2-8C97-48FC3979EB24Q33575791-4EF08EB3-424F-4ED5-BEA0-EFCC9A352859Q33647678-EC26EEB5-499B-4F32-AE88-9C34177E784CQ33713025-6AEFD56E-B52E-41F7-8895-AC050D0336BFQ33794201-A224B408-5B77-4B6B-BA3D-1EE3C9E7C39EQ33831193-28378579-7312-466B-9A64-4D68AE33E2AEQ33842218-889321DE-46B1-4773-A09C-4B5C418C3795Q34025078-974C0A7A-1CD9-4CCB-99AF-BAF5CFCE5773Q34576814-13626BC8-F67D-4133-BE92-9DF9D0AC27FAQ35701287-88B8870C-6BEF-4E65-8640-DDC475A43690Q36714202-5F4E2E89-67BF-4B5D-BE06-1D495C23FB0FQ37142004-91369916-0646-4F8F-8429-AD88B99D01DCQ37613647-5853D5CD-B40F-4227-857F-3EC5832AC600Q37684882-A71132CB-B310-404B-AA1C-979E7C7A8763Q38209315-0D04CFC5-31AC-4079-B516-B1139EB30B00Q38349381-286995C4-0C19-418A-96EA-6D2FC15A8599Q38383483-0DDC59D8-065E-4AB3-9F35-2F53AACF4F9EQ38718652-B45EE63C-65AE-40DD-8269-79F6C1E67279Q38829627-B7AEF807-3895-46C8-9D08-D70A6C788F59Q38892183-9FB004CF-C7A3-45AB-BF53-541FD8D1C70EQ38910562-AE721F24-6BBF-421F-B374-93684A7632BBQ38918949-C29C0B26-EFF3-42C6-A27D-A31845DF3E7EQ38991325-A98A58F8-CF77-4243-84A4-5E8425E28285Q39122705-1894DCBF-68A9-4EEB-87EB-391ACE2FE898Q42206315-12A336D5-FC16-43F7-B381-4BFDC1EC2B48Q42734908-E41FCE9C-2EA9-41B7-A912-DC127B27D2FAQ43211527-9BA0C1FD-64AD-4993-858D-8C5562ED3A8BQ43622376-1D183823-0800-470A-BBC0-D7C6FFBFE755Q45874784-AF326EC9-C537-4C7E-9477-D930DC3FF56CQ46449770-80370C37-F73C-4706-9A4E-DF90C7AAC6CDQ47131934-7C0B8AC1-E13A-4F9E-BAFB-C4BB9E71E393Q47693009-7E3DE7EE-9C1B-4F89-A3BC-F212DEA173ED
P2860
Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Enhancement of plasmid-mediate ...... directed plasmid integration.
@ast
Enhancement of plasmid-mediate ...... directed plasmid integration.
@en
Enhancement of plasmid-mediate ...... directed plasmid integration.
@nl
type
label
Enhancement of plasmid-mediate ...... directed plasmid integration.
@ast
Enhancement of plasmid-mediate ...... directed plasmid integration.
@en
Enhancement of plasmid-mediate ...... directed plasmid integration.
@nl
prefLabel
Enhancement of plasmid-mediate ...... directed plasmid integration.
@ast
Enhancement of plasmid-mediate ...... directed plasmid integration.
@en
Enhancement of plasmid-mediate ...... directed plasmid integration.
@nl
P2093
P2860
P356
P1476
Enhancement of plasmid-mediate ...... y directed plasmid integration
@en
P2093
Carmen Bertoni
Eric C Olivares
Michele P Calos
Sohail Jarrahian
Thurman M Wheeler
P2860
P304
P356
10.1073/PNAS.0504505102
P407
P577
2005-12-30T00:00:00Z